Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of VVZ-149 Injection PCA Regimen for Post-Operative Pain
KCT0010791Phase 2Completed
- Sponsor
- Vivozon
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of opiranserin in postoperative pain, sponsored by Vivozon. Started Jul 2025; status: completed.
02
Drugs
opiranserin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0010791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010791.